Cite

HARVARD Citation

    Manzoor, H. et al. (2023). Anti-PD-1 immunotherapy – Pembrolizumab current clinical trials for advanced head and neck cancer: A mapping systematic study. Oral oncology. p. . [Online]. 
  
Back to record